Mutational testing and its utility in thyroid cancer management: the need for something more

ISSN： 1752-0363

Source： Biomarkers in Medicine, Vol.7, Iss.4, 2013-08, pp. : 571-574

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Utility of molecular testing in the management of thyroid nodules – a clinical perspective

CYTOPATHOLOGY, Vol. 956-5507, Iss. 5, 2015-10 ,pp. : 284-287

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of Cancer in the Elderly: An Essential Need for More Clinically Relevant Data

Oncology, Vol. 85, Iss. 3, 2013-08 ,pp. : 166-167

Karger

Access to resources Recommend Favorite

In response to Does mutational analysis influence the management of differentiated thyroid cancers?

THE LARYNGOSCOPE, Vol. 128, Iss. 2, 2018-02 ,pp. : E85-E85

John Wiley & Sons Inc

Access to resources Recommend Favorite

In reference to Does mutational analysis influence the management of differentiated thyroid cancers?

THE LARYNGOSCOPE, Vol. 128, Iss. 2, 2018-02 ,pp. : E84-E84

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessment of cellularity, genomic DNA yields, and technical platforms for BRAF mutational testing in thyroid fine‐needle aspirate samples

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 2, 2014-02 ,pp. : 114-122

John Wiley & Sons Inc

Access to resources Recommend Favorite